J Korean Neurosurg Soc.  2004 Jun;35(6):599-604.

in vitro Biological Response of Malignant Glioma Cell Lines to Gamma Knife Irradiation

Affiliations
  • 1Department of Neurosurgery, Clinical Research Institute, Seoul National University College of Medicine, Seoul, Korea. hwnjung@snu.ac.kr

Abstract


OBJECTIVE
The effectiveness of gamma knife radiosurgery to malignant glioma has been controversial. The goal of this study is to elucidate the in vitro biological response of malignant glioma cells to gamma knife radiosurgery. METHODS: The human glioma cell lines U87 MG (p53-wild type) and U373 MG (p53-mutant type) were irradiated in vitro via Gamma Knife 23004B2 using specially designed well holder, with a maximal dose of 10, 20, 40, 80Gy. Those two cell lines were used to study a variety of gamma knife effects on morphological change by microscopic observation, on cell viability by MTT assay, on postirradiated apoptosis by annexin assay, and on cell cycle by flow cytometry. RESULTS: With increasing dosage, more spheroid cells were observed in tumor cells and this phenomenon peaked at the second day after gamma knife irradiation. MTT assay performed 3 hours after irradiation revealed reduced cell survival in the cells irradiated with over 20Gy (p=0.000). The annexin assay showed that apoptosis tended to increase on escalating the radiation dose in U87 cells. G2-M phase cell cycle arrest markedly increased 48 hours after irradiation, and this was more exaggerated in U373 MG than in U87 MG. CONCLUSION: These results suggest that the biological effect of gamma knife on malignant glioma cell line in vitro is mainly mediated by G2-M phase cell cycle arrest.

Keyword

Malignant glioma; In vitro; Gamma knife; Cell cycle

MeSH Terms

Apoptosis
Cell Cycle
Cell Cycle Checkpoints
Cell Line*
Cell Survival
Flow Cytometry
Glioma*
Humans
Radiosurgery
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr